Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02822508 · ClinicalTrials.gov registry record · Phase 2
A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 434
- Enrollment target
NCT02822508: Completed Phase 2 study, sponsored by Braintree Laboratories.
NCT02822508 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 434 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (226% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02822508, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 434 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.
Primary Outcome
Treatment response is defined as subjects who are weekly responders for at least 9 out of 12 weeks, with at least 3 of these weeks occurring in the last 4 weeks of treatment. A weekly responder is a subject who has ≥ 3 spontaneous bowel movements (SBMs) and an increase from baseline of \> 1 SBM in that week.
Interventions
- DRUG BLI801 Laxative
- DRUG BLI801 Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 434 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-04 |
| Phase | Phase 2 |
What the finished NCT02822508 record still lists
NCT02822508 is an interventional study that assigns participants to a tested intervention. The registered 434 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (226% higher).
The record links to 0 conditions, and to 2 interventions - of which BLI801 Laxative is the first listed.
NCT02822508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02822508 about?
NCT02822508 is a clinical study titled "A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation". The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.
What is the current status of trial NCT02822508?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 434 participants. The study started on 2016-06. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02822508?
The interventions under investigation include: BLI801 Laxative (DRUG), BLI801 Placebo (DRUG).
Who is sponsoring clinical trial NCT02822508?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02822508's enrollment target sits among peer trials
434 90th of 2000 higher than 1,911 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia